The annual symposium held in Bonn with the participation of authorities from the DACH region has developed into an industry meeting point in recent years. This time, a pre-symposium also focussed on the framework conditions for substance-based medical products with herbal active ingredients. These will change dramatically in the future in light of the European regulation on medical devices.